Authors: Luciani, LG Neulander, E Murphy, WM Wajsman, Z

Citation: Lg. Luciani et al., Risk of continued intravesical therapy and delayed cystectomy in BCG-refractory superficial bladder cancer: An investigational approach, UROLOGY, 58(3), 2001, pp. 376-379

Authors: Murphy, WM Rivera-Ramirez, I Luciani, LG Wajsman, Z

Citation: Wm. Murphy et al., Second opinion of anatomical pathology: A complex issue not easily reducedto matters of right and wrong, J UROL, 165(6), 2001, pp. 1957-1959

Authors: Neulander, EZ Rivera, I Wajsman, Z

Citation: Ez. Neulander et al., Re: Neoadjuvant hormonal ablative therapy before radical, prostatectomy: Areview. Is it indicated?, J UROL, 165(6), 2001, pp. 2008-2008

Authors: Patterson, AL Greenberg, RE Weems, L Bahnson, R Wajsman, Z Israel, M Sweatman, T Webber, D Gulfo, J

Citation: Al. Patterson et al., Pilot study of the tolerability and toxicity of intravesical valrubicin immediately after transurethral resection of superficial bladder cancer, UROLOGY, 56(2), 2000, pp. 232-235

Authors: Neulander, EZ Rivera, I Eisenbrown, N Wajsman, Z

Citation: Ez. Neulander et al., Simple cystectomy in patients requiring urinary diversion, J UROL, 164(4), 2000, pp. 1169-1172

Authors: Steinberg, G Bahnson, R Brosman, S Middleton, R Wajsman, Z Wehle, M

Citation: G. Steinberg et al., Efficacy and safety of valrubicin for the treatment of bacillus Calmette-Guerin refractory carcinoma in situ of the bladder, J UROL, 163(3), 2000, pp. 761-767